Search

Genetic Testing with IVF

Up to 70% of all embryos created do not survive the first three months of pregnancy, and many don’t achieve implantation because of a specific known genetic condition or chromosome abnormality.

For over a decade our national Boston IVF network of laboratories has performed groundbreaking genetic techniques that allow us to identify which embryos are most likely to result in a healthy pregnancy. Through tests like PGT-A and PGT-M, our team of scientists and embryologists analyze the genetic makeup of each embryo to eliminate abnormalities and gene disorders.

These crucial genetic tests improve IVF success rates and help to ensure you give birth to a healthy baby.

PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDIES (PGT-A)

PGT-A screens an embryo for chromosomal abnormalities prior to implantation and determines whether or not it has the correct number of chromosomes.

PGT-A is an extremely valuable option that helps increase the success of IVF, as chromosomal errors (aneuploidy) in embryos lead to their failure to implant and cause most miscarriages.

CaptureThis test increases pregnancy success rates and is a valuable option for women of advanced age, as well as women who have experienced recurrent miscarriage or multiple unsuccessful IVF cycles.

WHO DOES PGT-A HELP?

We suggest PGT-A for the following patient populations:

  • individuals or couples over 35 years old
  • individuals or couples who have experienced several unsuccessful IVF cycles
  • individuals and couples whose prior IVF failures are unexplained
  • individuals or couples who have experienced multiple miscarriages

WHAT ARE THE BENEFITS OF PGT-A?

  • PGT-A increases your fertility success rates
  • PGT-A increases your chance of a genetically normal embryo being selected
  • PGT-A increases your chance of an embryo implanting successfully
  • PGT-A reduces the need for multiple IVF cycles
  • PGT-A reduces the likelihood of having a miscarriage
  • PGT-A test results are ready in just 2-3 weeks

geneticsDOES PGT-A HELP WOMEN OF ADVANCED AGE?

Absolutely. PGT-A screens an embryo for abnormalities, increases pregnancy rates, and reduces miscarriage rates.

As a woman ages, her risk of chromosome and genetic abnormalities increases. This causes a lower chance of pregnancy and a higher chance of miscarriage.

If you are close to or over the age of 40, or have had recurrent miscarriages, been through several unsuccessful IVF cycles, this extremely accurate test can help determine if your embryo is healthy before implantation.

PREIMPLANTATION GENETIC TESTING FOR MONOGENIC/SINGLE GENE DEFECTS (PGT-M)

PGT-M is a genetic test, done in conjunction with IVF, which analyzes an embryos for a specific genetic disease. By removing just one cell from an embryo, our genetic technologies have the ability to successfully detect any genetic mutations.

It improves the likelihood of a successful pregnancy and birth for individuals and couples who are at risk for passing on an inherited genetic disease to their children.

WHAT ARE THE BENEFITS OF PGT-M?

  • screens your embryos for over 400 hereditary diseases before they are transferred back into the uterus
  • reduces the chance of conceiving a child with a genetic factor
  • increases your chance of carrying and delivering a healthy baby

WHO DOES PGT-M HELP?

We suggest PGT-M for the following patient populations:

  • individuals or couples who have experienced several unexplained or unsuccessful IVF cycles
  • individuals or couples over 35 years old
  • individuals or couples who have experienced multiple miscarriages
  • individuals or couples who are carriers of a chromosomal abnormality
  • individuals or couples with a family history of Cystic Fibrosis, Fragile-X syndrome, Spinal Muscular Atrophy or Huntington’s disease

capture